|
hCD31
|
mCd31
|
hCD105
|
mCd105
|
hVEGFR1
|
mVegfr1
|
hVEGFR2
|
mVegfr2
|
hVEGFA
|
mVegfa
|
---|
mCd31
| 0.0251
| | | | | | | | | |
| 0.762
| | | | | | | | | |
hCD105
| 0.043 | 0.121 | | | | | | | | |
| 0.60 | 0.14 | | | | | | | | |
mCd105
| 0.040 | 0.928 | 0.189 | | | | | | | |
| 0.63 |
<0.0000001
|
0.02
| | | | | | | |
hVEGFR1
| 0.065 | 0.022 | -0.076 | 0.004 | | | | | | |
| 0.43 | 0.79 | 0.35 | 0.96 | | | | | | |
mVegfr1
| 0.076 | 0.851 | 0.305 | 0.877 | 0.006 | | | | | |
| 0.35 |
<0.0000001
|
<0.0002
|
<0.0000001
| 0.94 | | | | | |
hVEGFR2
| 0.010 | -0.029 | 0.232 | -0.036 | -0.036 | 0.070 | | | | |
| 0.91 | 0.72 |
<0.005
| 0.66 | 0.66 | 0.40 | | | | |
mVegfr2
| 0.003 | 0.912 | 0.173 | 0.919 | -0.017 | 0.858 | -0.090 | | | |
| 0.98 |
<0.0000001
|
<0.05
|
<0.0000001
| 0.83 |
<0.0000001
| 0.27 | | | |
hVEGFA
| 0.095 | 0.477 | 0.319 | 0.563 | 0.090 | 0.726 | 0.131 | 0.517 | | |
| 0.25 |
<0.0000001
|
<0.0002
|
<0.0000001
| 0.27 |
<0.0000001
| 0.11 |
<0.0000001
| | |
mVegfa
| 0.031 | 0.505 | 0.194 | 0.524 | 0.304 | 0.514 | 0.062 | 0.413 | 0.328 | |
| 0.70 |
<0.0000001
|
<0.05
|
<0.0000001
|
<0.0002
|
<0.0000001
| 0.45 |
<0.0000001
|
<0.00005
| |
% mouse cells
| -0.016 | 0.828 | 0.113 | 0.865 | 0.154 | 0.715 | -0.145 | 0.797 | 0.364 | 0.666 |
| 0.84 |
<0.0000001
| 0.17 |
<0.0000001
| 0.06 |
<0.0000001
| 0.08 |
<0.0000001
|
<0.000005
|
<0.0000001
|
- Results, expressed as N-fold differences in target gene expression relative to the mouse and human TBP genes (both the mouse and human TBP transcripts) and termed “Ntarget”, were determined as Ntarget = 2∆Ctsample , where the ∆Ct value of the sample was determined by subtracting the average Ct value of target gene (human or mouse) from the average Ct value of ‘Total-TBP’ gene). The Ntarget values of the tumor samples were subsequently normalized such that the value for mRNA level was 1 when Ct=35. Target mRNA levels that were total absence or very low (Ct > 38) in tumor samples were scored ‘0’ for non expressed. As for calculation of % of mouse cells, specific mouse Tbp gene expression and the expression of both the mouse and the human TBP genes were studied by real-time qRT-PCR using the mouse Tbp as target gene and the ‘Total-TBP’ as endogenous RNA control. Results, expressed as N-fold differences in specific mouse Tbp gene expression (using mouse Tbp primers) relative to the sum of the mouse and the human TBP gene expression (using ‘Total-TBP’ primers), termed NMm-TBP, are determined by theformula: NMm-TBP = 2DCtsample. The DCt value of the sample is determined by subtracting the Ct value of the mouse TBP gene from the Ct value of the Total TBP gene. The NMm-TBP values of the samples are subsequently normalized such that the median of NMm-TBP values of 4 mouse tissues was 100. As TBP is a ubiquitously expressed housekeeping gene, showing similar expression in our human and mouse tissues (Ct=27 for 5 ng cDNA), the final result (normalized NMm-TBP value) gives an estimate of the proportion of mouse cell content for a given xenograft. 1Spearman correlation coefficient, 2p value of Spearman rank correlation test, in bold when p is significant.